Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT03441893
Eligibility Criteria:
Inclusion Criteria:
* Patients with ulcerative colitis before therapy and surgery
* Residents of Tashkent region which does not have any complaints from the gastrointestinal tract (control group)
Exclusion Criteria:
* Patients with a diagnosis of Crohn's disease
* Patients with a toxic megacolon,
* Patients with a abdominal abscess, -
* Patients with a symptomatic colonic stricture,
* Patients with a stoma,
* Patients with a a history of colectomy,
* An increased risk of infectious complications (e.g. as a result of recent pyogenic infection, enteric pathogens detected on stool analysis, active or latent tuberculosis, immunodeficiency, hepatitis B or C, or recent live vaccination),
* Clinically meaningful laboratory abnormalities,
* Pregnancy or lactation,
* An unstable or uncontrolled medical disorder,
* An anticipated requirement for major surgery,
* Colonic dysplasia or adenomas,
* Malignant neoplasms.
* Patients which operated,
* Ever used immunosuppressants or biological drugs
* In the presence of pathologic bacteria in gut microbiota, including Clostridium difficile, Salmonella spp, Shigella spp, Campylobacter spp, Yersinia spp, and Mycobacteria.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03441893
Study Brief:
Protocol Section:
NCT03441893